Toll Free: 1-888-928-9744

Global Anti-Obesity Drug Industry 2016 Market Research Report

Published: May 11, 2016 | Pages: 159 | Publisher: QYResearch | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

The Global Anti-Obesity Drug Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Anti-Obesity Drug industry.

Firstly, the report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Anti-Obesity Drug market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status.

Secondly, development policies and plans are discussed as well as manufacturing processes and cost structures. This report also states import/export, supply and consumption figures as well as cost, price, revenue and gross margin by regions (United States, EU, China and Japan), and other regions can be added.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What's more, the Anti-Obesity Drug industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


 Table of Contents
1 Industry Overview of Anti-Obesity Drug 1.1 Definition and Specifications of Anti-Obesity Drug 1.1.1 Definition of Anti-Obesity Drug 1.1.2 Specifications of Anti-Obesity Drug 1.2 Classification of Anti-Obesity Drug 1.3 Applications of Anti-Obesity Drug 1.4 Industry Chain Structure of Anti-Obesity Drug 1.5 Industry Overview and Major Regions Status of Anti-Obesity Drug 1.5.1 Industry Overview of Anti-Obesity Drug 1.5.2 Global Major Regions Status of Anti-Obesity Drug 1.6 Industry Policy Analysis of Anti-Obesity Drug 1.7 Industry News Analysis of Anti-Obesity Drug 2 Manufacturing Cost Structure Analysis of Anti-Obesity Drug 2.1 Raw Material Suppliers and Price Analysis of Anti-Obesity Drug 2.2 Equipment Suppliers and Price Analysis of Anti-Obesity Drug 2.3 Labor Cost Analysis of Anti-Obesity Drug 2.4 Other Costs Analysis of Anti-Obesity Drug 2.5 Manufacturing Cost Structure Analysis of Anti-Obesity Drug 2.6 Manufacturing Process Analysis of Anti-Obesity Drug 3 Technical Data and Manufacturing Plants Analysis of Anti-Obesity Drug 3.1 Capacity and Commercial Production Date of Global Anti-Obesity Drug Major Manufacturers in 2015 3.2 Manufacturing Plants Distribution of Global Anti-Obesity Drug Major Manufacturers in 2015 3.3 R&D Status and Technology Source of Global Anti-Obesity Drug Major Manufacturers in 2015 3.4 Raw Materials Sources Analysis of Global Anti-Obesity Drug Major Manufacturers in 2015 4 Capacity, Production and Revenue Analysis of Anti-Obesity Drug by Regions, Types and Manufacturers 4.1 Global Capacity, Production and Revenue of Anti-Obesity Drug by Regions 2011-2016 4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Anti-Obesity Drug 2011-2016 4.3 Global Capacity, Production and Revenue of Anti-Obesity Drug by Types 2011-2016 4.4 Global Capacity, Production and Revenue of Anti-Obesity Drug by Manufacturers 2011-2016 5 Price, Cost, Gross and Gross Margin Analysis of Anti-Obesity Drug by Regions, Types and Manufacturers 5.1 Price, Cost, Gross and Gross Margin Analysis of Anti-Obesity Drug by Regions 2011-2016 5.2 Price, Cost, Gross and Gross Margin Analysis of Anti-Obesity Drug by Types 2011-2016 5.3 Price, Cost, Gross and Gross Margin Analysis of Anti-Obesity Drug by Manufacturers 2011-2016 6 Consumption Volume, Consumption Value and Sale Price Analysis of Anti-Obesity Drug by Regions, Types and Applications 6.1 Global Consumption Volume and Consumption Value of Anti-Obesity Drug by Regions 2011-2016 6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Anti-Obesity Drug 2011-2016 6.3 Global Consumption Volume and Consumption Value of Anti-Obesity Drug by Types 2011-2016 6.4 Global Consumption Volume and Consumption Value of Anti-Obesity Drug by Applications 2011-2016 6.5 Sale Price of Anti-Obesity Drug by Regions 2011-2016 6.6 Sale Price of Anti-Obesity Drug by Types 2011-2016 6.7 Sale Price of Anti-Obesity Drug by Applications 2011-2016 6.8 Market Share Analysis of Anti-Obesity Drug by Different Sale Price Levels 7 Supply, Import, Export and Consumption Analysis of Anti-Obesity Drug 7.1 Supply, Consumption and Gap of Anti-Obesity Drug 2011-2016 7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016 7.3 United States Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016 7.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016 7.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016 7.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016 8 Major Manufacturers Analysis of Anti-Obesity Drug 8.1 Pfizer 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.3 Capacity, Production, Price, Cost, Gross and Revenue 8.1.4 Contact Information 8.2 Merck 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.3 Capacity, Production, Price, Cost, Gross and Revenue 8.2.4 Contact Information 8.3 F. Hoffmann-La Roche 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.3 Capacity, Production, Price, Cost, Gross and Revenue 8.3.4 Contact Information 8.4 GlaxoSmithKline 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.3 Capacity, Production, Price, Cost, Gross and Revenue 8.4.4 Contact Information 8.5 AstraZeneca 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.3 Capacity, Production, Price, Cost, Gross and Revenue 8.5.4 Contact Information 8.6 Boehringer Ingelheim 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.3 Capacity, Production, Price, Cost, Gross and Revenue 8.6.4 Contact Information 8.7 Novo Nordisk 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.3 Capacity, Production, Price, Cost, Gross and Revenue 8.7.4 Contact Information 8.8 Eisai 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.3 Capacity, Production, Price, Cost, Gross and Revenue 8.8.4 Contact Information 8.9 Norgine 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.3 Capacity, Production, Price, Cost, Gross and Revenue 8.9.4 Contact Information 8.10 Arena Pharmaceuticals 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.3 Capacity, Production, Price, Cost, Gross and Revenue 8.10.4 Contact Information 8.11 Orexigen Therapeutics 8.11.1 Company Profile 8.11.2 Product Picture and Specifications 8.11.3 Capacity, Production, Price, Cost, Gross and Revenue 8.11.4 Contact Information 8.12 Vivus 8.12.1 Company Profile 8.12.2 Product Picture and Specifications 8.12.3 Capacity, Production, Price, Cost, Gross and Revenue 8.12.4 Contact Information 8.13 Alizyme 8.13.1 Company Profile 8.13.2 Product Picture and Specifications 8.13.3 Capacity, Production, Price, Cost, Gross and Revenue 8.13.4 Contact Information 8.14 Rhythm Pharmaceuticals 8.14.1 Company Profile 8.14.2 Product Picture and Specifications 8.14.3 Capacity, Production, Price, Cost, Gross and Revenue 8.14.4 Contact Information 8.15 Shionogi 8.15.1 Company Profile 8.15.2 Product Picture and Specifications 8.15.3 Capacity, Production, Price, Cost, Gross and Revenue 8.15.4 Contact Information 8.16 Zafgan 8.16.1 Company Profile 8.16.2 Product Picture and Specifications 8.16.3 Capacity, Production, Price, Cost, Gross and Revenue 8.16.4 Contact Information 9 Marketing Trader or Distributor Analysis of Anti-Obesity Drug 9.1 Marketing Channels Status of Anti-Obesity Drug 9.2 Traders or Distributors with Contact Information of Anti-Obesity Drug by Regions 9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Anti-Obesity Drug 9.4 Regional Import, Export and Trade Analysis of Anti-Obesity Drug 10 Industry Chain Analysis of Anti-Obesity Drug 10.1 Upstream Major Raw Materials Suppliers Analysis of Anti-Obesity Drug 10.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Anti-Obesity Drug 10.1.2 Major Raw Materials Suppliers with Supply Volume Analysis of Anti-Obesity Drug by Regions 10.2 Upstream Major Equipment Suppliers Analysis of Anti-Obesity Drug 10.2.1 Major Equipment Suppliers with Contact Information Analysis of Anti-Obesity Drug 10.2.2 Major Equipment Suppliers with Product Pictures Analysis of Anti-Obesity Drug by Regions 10.3 Downstream Major Consumers Analysis of Anti-Obesity Drug 10.3.1 Major Consumers with Contact Information Analysis of Anti-Obesity Drug 10.3.2 Major Consumers with Consumption Volume Analysis of Anti-Obesity Drug by Regions 10.4 Supply Chain Relationship Analysis of Anti-Obesity Drug 11 Development Trend of Analysis of Anti-Obesity Drug 11.1 Capacity, Production and Revenue Forecast of Anti-Obesity Drug by Regions and Types 11.1.1 Global Capacity, Production and Revenue of Anti-Obesity Drug by Regions 2016-2021 11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Anti-Obesity Drug 2016-2021 11.1.3 Global Capacity, Production and Revenue of Anti-Obesity Drug by Types 2016-2021 11.2 Consumption Volume and Consumption Value Forecast of Anti-Obesity Drug by Regions, Types and Applications 11.2.1 Global Consumption Volume and Consumption Value of Anti-Obesity Drug by Regions 2016-2021 11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Anti-Obesity Drug 2016-2021 11.2.3 Global Consumption Volume and Consumption Value of Anti-Obesity Drug by Types 2016-2021 11.2.4 Global Consumption Volume and Consumption Value of Anti-Obesity Drug by Applications 2016-2021 11.3 Supply, Import, Export and Consumption Forecast of Anti-Obesity Drug 11.3.1 Supply, Consumption and Gap of Anti-Obesity Drug 2016-2021 11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021 11.3.3 United States Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021 11.3.4 EU Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021 11.3.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021 11.3.6 Japan Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021 12 New Project Investment Feasibility Analysis of Anti-Obesity Drug 12.1 New Project SWOT Analysis of Anti-Obesity Drug 12.2 New Project Investment Feasibility Analysis of Anti-Obesity Drug 13 Conclusion of the Global Anti-Obesity Drug Industry 2016 Market Research Report
List of Tables and Figures
Figure Picture of Anti-Obesity Drug Table Product Specifications of Anti-Obesity Drug Table Classification of Anti-Obesity Drug Figure Global Production Market Share of Anti-Obesity Drug by Types in 2015 Table Applications of Anti-Obesity Drug Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Applications in 2015 Figure Industry Chain Structure of Anti-Obesity Drug Table Global Anti-Obesity Drug Major Manufacturers Table Global Major Regions Anti-Obesity Drug Development Status Table Industry Policy of Anti-Obesity Drug Table Industry News List of Anti-Obesity Drug Table Raw Material Suppliers and Price Analysis Table Equipment Suppliers and Price Analysis Table Manufacturing Cost Structure Analysis of Anti-Obesity Drug in 2015 Figure Manufacturing Process Analysis of Anti-Obesity Drug Table Capacity (K Doses) and Commercial Production Date of Global Anti-Obesity Drug Major Manufacturers in 2015 Table Manufacturing Plants Distribution of Global Anti-Obesity Drug Major Manufacturers in 2015 Table R&D Status and Technology Source of Global Anti-Obesity Drug Major Manufacturers in 2015 Table Raw Materials Sources Analysis of Global Anti-Obesity Drug Major Manufacturers in 2015 Table Global Capacity (K Doses) of Anti-Obesity Drug by Regions 2011-2016 Figure Global Capacity Market Share of Anti-Obesity Drug by Regions in 2011 Figure Global Capacity Market Share of Anti-Obesity Drug by Regions in 2015 Table Global Production (K Doses) of Anti-Obesity Drug by Regions 2011-2016 Figure Global Production Market Share of Anti-Obesity Drug by Regions in 2011 Figure Global Production Market Share of Anti-Obesity Drug by Regions in 2015 Table Global Revenue (M USD) of Anti-Obesity Drug by Regions 2011-2016 Figure Global Revenue Market Share of Anti-Obesity Drug by Regions in 2011 Figure Global Revenue Market Share of Anti-Obesity Drug by Regions in 2015 Figure Global Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure Global Capacity Utilization Rate of Anti-Obesity Drug 2011-2016 Figure Global Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure United States Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure United States Capacity Utilization Rate of Anti-Obesity Drug 2011-2016 Figure United States Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure EU Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure EU Capacity Utilization Rate of Anti-Obesity Drug 2011-2016 Figure EU Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure China Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure China Capacity Utilization Rate of Anti-Obesity Drug 2011-2016 Figure China Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure Japan Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure Japan Capacity Utilization Rate of Anti-Obesity Drug 2011-2016 Figure Japan Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016 Table Global Capacity (K Doses) of Anti-Obesity Drug by Types 2011-2016 Figure Global Capacity Market Share of Anti-Obesity Drug by Types in 2011 Figure Global Capacity Market Share of Anti-Obesity Drug by Types in 2015 Table Global Production (K Doses) of Anti-Obesity Drug by Types 2011-2016 Figure Global Production Market Share of Anti-Obesity Drug by Types in 2011 Figure Global Production Market Share of Anti-Obesity Drug by Types in 2015 Table Global Revenue (M USD) of Anti-Obesity Drug by Types 2011-2016 Figure Global Revenue Market Share of Anti-Obesity Drug by Types in 2011 Figure Global Revenue Market Share of Anti-Obesity Drug by Types in 2015 Table Global and Major Manufacturers Capacity (K Doses) of Anti-Obesity Drug 2011-2016 Table Global Capacity Market Share of Anti-Obesity Drug Major Manufacturers 2011-2016 Figure Global Capacity Market Share of Anti-Obesity Drug Major Manufacturers in 2011 Figure Global Capacity Market Share of Anti-Obesity Drug Major Manufacturers in 2015 Table Global and Major Manufacturers Production (K Doses) of Anti-Obesity Drug 2011-2016 Table Global Production Market Share of Anti-Obesity Drug Major Manufacturers 2011-2016 Figure Global Production Market Share of Anti-Obesity Drug Major Manufacturers in 2011 Figure Global Production Market Share of Anti-Obesity Drug Major Manufacturers in 2015 Table Global and Major Manufacturers Revenue (M USD) of Anti-Obesity Drug 2011-2016 Table Global Revenue Market Share of Anti-Obesity Drug Major Manufacturers 2011-2016 Figure Global Revenue Market Share of Anti-Obesity Drug Major Manufacturers in 2011 Figure Global Revenue Market Share of Anti-Obesity Drug Major Manufacturers in 2015 Table Price (USD/Dose) of Anti-Obesity Drug by Regions 2011-2016 Figure Price (USD/Dose) of Anti-Obesity Drug by Regions in 2015 Table Cost (USD/Dose) of Anti-Obesity Drug by Regions 2011-2016 Figure Cost (USD/Dose) of Anti-Obesity Drug by Regions in 2015 Table Gross (USD/Dose) of Anti-Obesity Drug by Regions 2011-2016 Figure Gross (USD/Dose) of Anti-Obesity Drug by Regions in 2015 Table Gross Margin of Anti-Obesity Drug by Regions 2011-2016 Figure Gross Margin of Anti-Obesity Drug by Regions in 2015 Table Price (USD/Dose) of Anti-Obesity Drug by Types 2011-2016 Figure Price (USD/Dose) of Anti-Obesity Drug by Types in 2015 Table Cost (USD/Dose) of Anti-Obesity Drug by Types 2011-2016 Figure Cost (USD/Dose) of Anti-Obesity Drug by Types in 2015 Table Gross (USD/Dose) of Anti-Obesity Drug by Types 2011-2016 Figure Gross (USD/Dose) of Anti-Obesity Drug by Types in 2015 Table Gross Margin of Anti-Obesity Drug by Types 2011-2016 Figure Gross Margin of Anti-Obesity Drug by Types in 2015 Table Price (USD/Dose) of Anti-Obesity Drug by Manufacturers 2011-2016 Figure Price (USD/Dose) of Anti-Obesity Drug by Manufacturers in 2015 Table Cost (USD/Dose) of Anti-Obesity Drug by Manufacturers 2011-2016 Figure Cost (USD/Dose) of Anti-Obesity Drug by Manufacturers in 2015 Table Gross (USD/Dose) of Anti-Obesity Drug by Manufacturers 2011-2016 Figure Gross (USD/Dose) of Anti-Obesity Drug by Manufacturers in 2015 Table Gross Margin of Anti-Obesity Drug by Manufacturers 2011-2016 Figure Gross Margin of Anti-Obesity Drug by Manufacturers in 2015 Table Global Consumption Volume (K Doses) of Anti-Obesity Drug by Regions 2011-2016 Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Regions in 2011 Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Regions in 2015 Table Global Consumption Value (M USD) of Anti-Obesity Drug by Regions 2011-2016 Figure Global Consumption Value Market Share of Anti-Obesity Drug by Regions in 2011 Figure Global Consumption Value Market Share of Anti-Obesity Drug by Regions in 2015 Figure Global Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure Global Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure United States Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure United States Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure EU Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure EU Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure China Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure China Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure Japan Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2011-2016 Figure Japan Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2011-2016 Table Global Consumption Volume (K Doses) of Anti-Obesity Drug by Types 2011-2016 Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Types in 2011 Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Types in 2015 Table Global Consumption Value (M USD) of Anti-Obesity Drug by Types 2011-2016 Figure Global Consumption Value Market Share of Anti-Obesity Drug by Types in 2011 Figure Global Consumption Value Market Share of Anti-Obesity Drug by Types in 2015 Table Global Consumption Volume (K Doses) of Anti-Obesity Drug by Applications 2011-2016 Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Applications in 2011 Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Applications in 2015 Table Global Consumption Value (M USD) of Anti-Obesity Drug by Applications 2011-2016 Figure Global Consumption Value Market Share of Anti-Obesity Drug by Applications in 2011 Figure Global Consumption Value Market Share of Anti-Obesity Drug by Applications in 2015 Table Sale Price (USD/Dose) of Anti-Obesity Drug by Regions 2011-2016 Figure Sale Price (USD/Dose) of Anti-Obesity Drug by Regions in 2015 Table Sale Price (USD/Dose) of Anti-Obesity Drug by Types 2011-2016 Figure Sale Price (USD/Dose) of Anti-Obesity Drug by Types in 2015 Table Sale Price (USD/Dose) of Anti-Obesity Drug by Applications 2011-2016 Figure Sale Price (USD/Dose) of Anti-Obesity Drug by Applications in 2015 Table Market Share of Anti-Obesity Drug by Different Sale Price Levels Table Global Supply, Consumption and Gap of Anti-Obesity Drug 2011-2016 (K Doses) Table United States Supply, Consumption and Gap of Anti-Obesity Drug 2011-2016 (K Doses) Table EU Supply, Consumption and Gap of Anti-Obesity Drug 2011-2016 (K Doses) Table China Supply, Consumption and Gap of Anti-Obesity Drug 2011-2016 (K Doses) Table Japan Supply, Consumption and Gap of Anti-Obesity Drug 2011-2016 (K Doses) Table Global Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2011-2016 Table United States Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2011-2016 Table United States Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016 (K Doses) Table EU Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2011-2016 Table EU Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016 (K Doses) Table China Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2011-2016 Table China Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016 (K Doses) Table Japan Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2011-2016 Table Japan Supply, Import, Export and Consumption of Anti-Obesity Drug 2011-2016 (K Doses) Table Pfizer Information List Figure Anti-Obesity Drug Picture and Specifications of Pfizer Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Pfizer 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Pfizer 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Pfizer 2011-2016 Table Merck Information List Figure Anti-Obesity Drug Picture and Specifications of Merck Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Merck 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Merck 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Merck 2011-2016 Table F. Hoffmann-La Roche Information List Figure Anti-Obesity Drug Picture and Specifications of F. Hoffmann-La Roche Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of F. Hoffmann-La Roche 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of F. Hoffmann-La Roche 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of F. Hoffmann-La Roche 2011-2016 Table GlaxoSmithKline Information List Figure Anti-Obesity Drug Picture and Specifications of GlaxoSmithKline Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GlaxoSmithKline 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of GlaxoSmithKline 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of GlaxoSmithKline 2011-2016 Table AstraZeneca Information List Figure Anti-Obesity Drug Picture and Specifications of AstraZeneca Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of AstraZeneca 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of AstraZeneca 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of AstraZeneca 2011-2016 Table Boehringer Ingelheim Information List Figure Anti-Obesity Drug Picture and Specifications of Boehringer Ingelheim Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Boehringer Ingelheim 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Boehringer Ingelheim 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Boehringer Ingelheim 2011-2016 Table Novo Nordisk Information List Figure Anti-Obesity Drug Picture and Specifications of Novo Nordisk Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Novo Nordisk 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Novo Nordisk 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Novo Nordisk 2011-2016 Table Eisai Information List Figure Anti-Obesity Drug Picture and Specifications of Eisai Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Eisai 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Eisai 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Eisai 2011-2016 Table Norgine Information List Figure Anti-Obesity Drug Picture and Specifications of Norgine Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Norgine 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Norgine 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Norgine 2011-2016 Table Arena Pharmaceuticals Information List Figure Anti-Obesity Drug Picture and Specifications of Arena Pharmaceuticals Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Arena Pharmaceuticals 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Arena Pharmaceuticals 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Arena Pharmaceuticals 2011-2016 Table Orexigen Therapeutics Information List Figure Anti-Obesity Drug Picture and Specifications of Orexigen Therapeutics Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Orexigen Therapeutics 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Orexigen Therapeutics 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Orexigen Therapeutics 2011-2016 Table Vivus Information List Figure Anti-Obesity Drug Picture and Specifications of Vivus Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Vivus 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Vivus 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Vivus 2011-2016 Table Alizyme Information List Figure Anti-Obesity Drug Picture and Specifications of Alizyme Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Alizyme 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Alizyme 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Alizyme 2011-2016 Table Rhythm Pharmaceuticals Information List Figure Anti-Obesity Drug Picture and Specifications of Rhythm Pharmaceuticals Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Rhythm Pharmaceuticals 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Rhythm Pharmaceuticals 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Rhythm Pharmaceuticals 2011-2016 Table Shionogi Information List Figure Anti-Obesity Drug Picture and Specifications of Shionogi Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Shionogi 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Shionogi 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Shionogi 2011-2016 Table Zafgan Information List Figure Anti-Obesity Drug Picture and Specifications of Zafgan Table Anti-Obesity Drug Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Zafgan 2011-2016 Figure Anti-Obesity Drug Capacity (K Doses), Production (K Doses) and Growth Rate of Zafgan 2011-2016 Figure Anti-Obesity Drug Production (K Doses) and Global Market Share of Zafgan 2011-2016 Figure Marketing Channels of Anti-Obesity Drug Table Traders or Distributors with Contact Information of Anti-Obesity Drug by Regions Table Ex-work Price, Channel Price and End Buyer Price of Anti-Obesity Drug (USD/Dose) Table Regional Import, Export, and Trade of Anti-Obesity Drug (K Doses) Table Flow of International Trade in 2015 Table Major Raw Materials Suppliers with Contact Information of Anti-Obesity Drug Table Major Raw Materials Suppliers with Supply Volume of Anti-Obesity Drug by Regions Table Major Equipment Suppliers with Contact Information of Anti-Obesity Drug Table Major Equipment Suppliers with Product Pictures of Anti-Obesity Drug by Regions Table Major Consumers with Contact Information of Anti-Obesity Drug Table Major Consumers with Consumption Volume of Anti-Obesity Drug by Regions Figure Supply Chain Relationship Analysis of Anti-Obesity Drug Table Global Capacity (K Doses) of Anti-Obesity Drug by Regions 2016-2021 Figure Global Capacity Market Share of Anti-Obesity Drug by Regions in 2016 Figure Global Capacity Market Share of Anti-Obesity Drug by Regions in 2021 Table Global Production (K Doses) of Anti-Obesity Drug by Regions 2016-2021 Figure Global Production Market Share of Anti-Obesity Drug by Regions in 2016 Figure Global Production Market Share of Anti-Obesity Drug by Regions in 2021 Table Global Revenue (M USD) of Anti-Obesity Drug by Regions 2016-2021 Figure Global Revenue Market Share of Anti-Obesity Drug by Regions in 2016 Figure Global Revenue Market Share of Anti-Obesity Drug by Regions in 2021 Figure Global Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure Global Capacity Utilization Rate of Anti-Obesity Drug 2016-2021 Figure Global Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure United States Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure United States Capacity Utilization Rate of Anti-Obesity Drug 2016-2021 Figure United States Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure EU Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure EU Capacity Utilization Rate of Anti-Obesity Drug 2016-2021 Figure EU Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure China Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure China Capacity Utilization Rate of Anti-Obesity Drug 2016-2021 Figure China Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure Japan Capacity (K Doses), Production (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure Japan Capacity Utilization Rate of Anti-Obesity Drug 2016-2021 Figure Japan Revenue (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021 Table Global Capacity (K Doses) of Anti-Obesity Drug by Types 2016-2021 Figure Global Capacity Market Share of Anti-Obesity Drug by Types in 2016 Figure Global Capacity Market Share of Anti-Obesity Drug by Types in 2021 Table Global Production (K Doses) of Anti-Obesity Drug by Types 2016-2021 Figure Global Production Market Share of Anti-Obesity Drug by Types in 2016 Figure Global Production Market Share of Anti-Obesity Drug by Types in 2021 Table Global Revenue (M USD) of Anti-Obesity Drug by Types 2016-2021 Figure Global Revenue Market Share of Anti-Obesity Drug by Types in 2016 Figure Global Revenue Market Share of Anti-Obesity Drug by Types in 2021 Table Global Consumption Volume (K Doses) of Anti-Obesity Drug by Regions 2016-2021 Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Regions in 2016 Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Regions in 2021 Table Global Consumption Value (M USD) of Anti-Obesity Drug by Regions 2016-2021 Figure Global Consumption Value Market Share of Anti-Obesity Drug by Regions in 2016 Figure Global Consumption Value Market Share of Anti-Obesity Drug by Regions in 2021 Figure Global Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure Global Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure United States Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure United States Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure EU Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure EU Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure China Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure China Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure Japan Consumption Volume (K Doses) and Growth Rate of Anti-Obesity Drug 2016-2021 Figure Japan Consumption Value (M USD) and Growth Rate of Anti-Obesity Drug 2016-2021 Table Global Consumption Volume (K Doses) of Anti-Obesity Drug by Types 2016-2021 Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Types in 2016 Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Types in 2021 Table Global Consumption Value (M USD) of Anti-Obesity Drug by Types 2016-2021 Figure Global Consumption Value Market Share of Anti-Obesity Drug by Types in 2016 Figure Global Consumption Value Market Share of Anti-Obesity Drug by Types in 2021 Table Global Consumption Volume (K Doses) of Anti-Obesity Drug by Applications 2016-2021 Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Applications in 2016 Figure Global Consumption Volume Market Share of Anti-Obesity Drug by Applications in 2021 Table Global Consumption Value (M USD) of Anti-Obesity Drug by Applications 2016-2021 Figure Global Consumption Value Market Share of Anti-Obesity Drug by Applications in 2016 Figure Global Consumption Value Market Share of Anti-Obesity Drug by Applications in 2021 Table Global Supply, Consumption and Gap of Anti-Obesity Drug 2016-2021 (K Doses) Table United States Supply, Consumption and Gap of Anti-Obesity Drug 2016-2021 (K Doses) Table EU Supply, Consumption and Gap of Anti-Obesity Drug 2016-2021 (K Doses) Table China Supply, Consumption and Gap of Anti-Obesity Drug 2016-2021 (K Doses) Table Japan Supply, Consumption and Gap of Anti-Obesity Drug 2016-2021 (K Doses) Table Global Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2016-2021 Table United States Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2016-2021 Table United States Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021 (K Doses) Table EU Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2016-2021 Table EU Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021 (K Doses) Table China Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2016-2021 Table China Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021 (K Doses) Table Japan Capacity (K Doses), Production (K Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Anti-Obesity Drug 2016-2021 Table Japan Supply, Import, Export and Consumption of Anti-Obesity Drug 2016-2021 (K Doses) Table New Project SWOT Analysis of Anti-Obesity Drug Table New Project Investment Feasibility Analysis of Anti-Obesity Drug Table Part of Interviewees Record List



To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global fumaric acid market size is anticipated to be valued at USD 764.8 million by 2020, as per a new research report by Radiant Insights, Inc. Growing processed food demand coupled with RTD (ready-to-drink) beverages consumption is expected to driv

Read More...

Global commercial drone market size is estimated to reach USD 2,069.6 million by 2022, as per a new research report by Radiant Insights, Inc. Increasing application of these machines in various industry sectors such as military, agriculture and energ

Read More...

North America air conditioner market size is expected to be valued at USD 52,560.7 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing usage of energy efficient air conditioners owing to declining energy consumption rat

Read More...

Europe industrial air filtration market size is projected to reach USD 1,690.8 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing implementation in various industries such as metal, cement and food & beverages among ot

Read More...

Global contact lenses market size is estimated to reach USD 12.5 billion by 2020, according to a new industry report by Radiant Insights, Inc. Growing number of ophthalmic disorder observed in global population especially children is likely to drive

Read More...
Choose License Type
Single User - US $2800
Multi User - US $5600
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify